Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Smart for Life, Inc. (SMFL)

  • Business News
  • Jan. 22, 2026, 20:19 UTC
  • 1
  • 1 comments

This Meeting Could Have Been an Email

Market reaction Comment Full text

Century Therapeutics Inc (IPSC)

  • Technical Exchange News
  • Jan. 22, 2026, 20:05 UTC
  • 7
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Autonomix Medical Inc. (AMIX)

  • Technical Exchange News
  • Jan. 22, 2026, 20:04 UTC
  • 6
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

SOBR Safe, Inc. (SOBR)

  • SEC News
  • Jan. 22, 2026, 19:49 UTC
  • 2
  • 0 comments

New Form 424B3 - SOBR Safe, Inc. Filed: 2026-01-22 AccNo: 0001477932-26-000335 Size: 245 KB

Comment Full text

RAMI LEVY REAL ESTATE LTD (RLRE)

  • SEC News
  • Jan. 22, 2026, 19:31 UTC
  • 2
  • 1 comments

Обновление данных компании RAMI LEVY REAL ESTATE LTD (7 изменений)

Comment Full text

RAMI LEVI RE (RLRE)

  • Technical Exchange News
  • Jan. 22, 2026, 18:33 UTC
  • 5
  • 0 comments

RAMI LEVI RE (RLRE) was added to the list of traded instruments on TASE exchange

Comment Full text

Trevi Therapeutics Inc. (TRVI)

  • Business News
  • Jan. 22, 2026, 17:32 UTC
  • 4
  • 1 comments

Trevi Therapeutics Announces Publication of Data from the Phase 2b IPF Chronic Cough Trial of nalbuphine ER in the Journal of the American Medical Association (JAMA)

Market reaction Comment Full text

FARO Technologies Inc (FARO)

  • Business News
  • Jan. 22, 2026, 16:45 UTC
  • 2
  • 1 comments

A New Era Unfolds: FARO and Creaform Combine to Form Two New Business Units

Market reaction Comment Full text

Novanta Inc (NOVT)

  • Business News
  • Jan. 22, 2026, 16:00 UTC
  • 1
  • 1 comments

Novanta - Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 24, 2026

Market reaction Comment Full text

National Research (NRC)

  • Business News
  • Jan. 22, 2026, 15:27 UTC
  • 1
  • 1 comments

The Latest from NRC Health | Advancing equity, addressing AI in healthcare, patient experience as a strategic asset, and more!

Market reaction Comment Full text

NKGen Biotech Inc (NKGNW)

  • Business News
  • Jan. 22, 2026, 15:12 UTC
  • 1
  • 1 comments

NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. to Scientific Advisory Board

Market reaction Comment Full text

Instil Bio Inc (TIL)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL

Market reaction Comment Full text

Ultragenyx Pharmaceutical Inc (RARE)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 0
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE

Market reaction Comment Full text

agilon health Inc (AGL)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 0
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming Deadlines - AGL

Market reaction Comment Full text

Organogenesis Holdings Inc. (ORGO)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

Market reaction Comment Full text
  • Previous
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next

Search

News categories

  • Technical Exchange News(10841)
  • Event(2204)
  • SEC News(187798)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124250)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin